IGC Pharma
31 hedge funds and large institutions have $2.37M invested in IGC Pharma in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.84% more ownership
Funds ownership: 1.06% → 3.9% (+2.8%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
31
Holding in Top 10
–
Calls
$116K
Puts
$58K
Top Buyers
| 1 | +$745K | |
| 2 | +$352K | |
| 3 | +$325K | |
| 4 |
VF
Virtu Financial
New York
|
+$85K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$68K |
Top Sellers
| 1 | -$44.2K | |
| 2 | -$32.9K | |
| 3 | -$12K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$4.17K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$3.01K |